ID   TRAC_HUMAN              Reviewed;         140 AA.
AC   P01848; A0A087WWC6;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   18-JUL-2018, sequence version 2.
DT   28-JAN-2026, entry version 190.
DE   RecName: Full=T cell receptor alpha chain constant {ECO:0000303|Ref.4};
GN   Name=TRAC {ECO:0000303|Ref.4}; Synonyms=TCRA;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (IMGT ALLELE TRAC*01).
RX   PubMed=3875483; DOI=10.1002/j.1460-2075.1985.tb03803.x;
RA   Rabbitts T.H., Lefranc M.P., Stinson M.A., Sims J.E., Schroder J.,
RA   Steinmetz M., Spurr N.L., Solomon E., Goodfellow P.N.;
RT   "The chromosomal location of T-cell receptor genes and a T cell rearranging
RT   gene: possible correlation with specific translocations in human T cell
RT   leukaemia.";
RL   EMBO J. 4:1461-1465(1985).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (IMGT ALLELE TRAC*01).
RX   PubMed=3873654; DOI=10.1073/pnas.82.10.3430;
RA   Yanagi Y., Chan A., Chin B., Minden M., Mak T.W.;
RT   "Analysis of cDNA clones specific for human T cells and the alpha and beta
RT   chains of the T-cell receptor heterodimer from a human T-cell line.";
RL   Proc. Natl. Acad. Sci. U.S.A. 82:3430-3434(1985).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA] (IMGT ALLELE TRAC*01).
RX   PubMed=12508121; DOI=10.1038/nature01348;
RA   Heilig R., Eckenberg R., Petit J.-L., Fonknechten N., Da Silva C.,
RA   Cattolico L., Levy M., Barbe V., De Berardinis V., Ureta-Vidal A.,
RA   Pelletier E., Vico V., Anthouard V., Rowen L., Madan A., Qin S., Sun H.,
RA   Du H., Pepin K., Artiguenave F., Robert C., Cruaud C., Bruels T.,
RA   Jaillon O., Friedlander L., Samson G., Brottier P., Cure S., Segurens B.,
RA   Aniere F., Samain S., Crespeau H., Abbasi N., Aiach N., Boscus D.,
RA   Dickhoff R., Dors M., Dubois I., Friedman C., Gouyvenoux M., James R.,
RA   Madan A., Mairey-Estrada B., Mangenot S., Martins N., Menard M., Oztas S.,
RA   Ratcliffe A., Shaffer T., Trask B., Vacherie B., Bellemere C., Belser C.,
RA   Besnard-Gonnet M., Bartol-Mavel D., Boutard M., Briez-Silla S.,
RA   Combette S., Dufosse-Laurent V., Ferron C., Lechaplais C., Louesse C.,
RA   Muselet D., Magdelenat G., Pateau E., Petit E., Sirvain-Trukniewicz P.,
RA   Trybou A., Vega-Czarny N., Bataille E., Bluet E., Bordelais I., Dubois M.,
RA   Dumont C., Guerin T., Haffray S., Hammadi R., Muanga J., Pellouin V.,
RA   Robert D., Wunderle E., Gauguet G., Roy A., Sainte-Marthe L., Verdier J.,
RA   Verdier-Discala C., Hillier L.W., Fulton L., McPherson J., Matsuda F.,
RA   Wilson R., Scarpelli C., Gyapay G., Wincker P., Saurin W., Quetier F.,
RA   Waterston R., Hood L., Weissenbach J.;
RT   "The DNA sequence and analysis of human chromosome 14.";
RL   Nature 421:601-607(2003).
RN   [4]
RP   NOMENCLATURE.
RA   Lefranc M.P., Lefranc G.;
RT   "The T Cell Receptor FactsBook.";
RL   (In) Lefranc M.P., Lefranc G. (eds.);
RL   The T Cell Receptor FactsBook., pp.1-397, Academic Press, London. (2001).
RN   [5]
RP   REVIEW ON T CELL REPERTOIRE DIVERSITY.
RX   PubMed=15040585; DOI=10.1038/nri1292;
RA   Nikolich-Zugich J., Slifka M.K., Messaoudi I.;
RT   "The many important facets of T-cell repertoire diversity.";
RL   Nat. Rev. Immunol. 4:123-132(2004).
RN   [6]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-32 AND ASN-66.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19349973; DOI=10.1038/nbt.1532;
RA   Wollscheid B., Bausch-Fluck D., Henderson C., O'Brien R., Bibel M.,
RA   Schiess R., Aebersold R., Watts J.D.;
RT   "Mass-spectrometric identification and relative quantification of N-linked
RT   cell surface glycoproteins.";
RL   Nat. Biotechnol. 27:378-386(2009).
RN   [7]
RP   REVIEW ON T CELL RECEPTOR-CD3 COMPLEX ASSEMBLY, AND SUBCELLULAR LOCATION.
RX   PubMed=20452950; DOI=10.1101/cshperspect.a005140;
RA   Wucherpfennig K.W., Gagnon E., Call M.J., Huseby E.S., Call M.E.;
RT   "Structural biology of the T-cell receptor: insights into receptor
RT   assembly, ligand recognition, and initiation of signaling.";
RL   Cold Spring Harb. Perspect. Biol. 2:A005140-A005140(2010).
RN   [8]
RP   REVIEW ON T CELL RECEPTOR SIGNALING.
RX   PubMed=23524462; DOI=10.1038/nri3403;
RA   Brownlie R.J., Zamoyska R.;
RT   "T cell receptor signalling networks: branched, diversified and bounded.";
RL   Nat. Rev. Immunol. 13:257-269(2013).
RN   [9]
RP   NOMENCLATURE.
RX   PubMed=24600447; DOI=10.3389/fimmu.2014.00022;
RA   Lefranc M.P.;
RT   "Immunoglobulin and T Cell Receptor Genes: IMGT((R)) and the Birth and Rise
RT   of Immunoinformatics.";
RL   Front. Immunol. 5:22-22(2014).
RN   [10]
RP   REVIEW ON FUNCTION.
RX   PubMed=25493333; DOI=10.1146/annurev-immunol-032414-112334;
RA   Rossjohn J., Gras S., Miles J.J., Turner S.J., Godfrey D.I., McCluskey J.;
RT   "T cell antigen receptor recognition of antigen-presenting molecules.";
RL   Annu. Rev. Immunol. 33:169-200(2015).
RN   [11]
RP   DISULFIDE BOND, SUBUNIT, DOMAIN, AND MUTAGENESIS OF ASN-130.
RX   PubMed=27791034; DOI=10.1073/pnas.1611445113;
RA   Krshnan L., Park S., Im W., Call M.J., Call M.E.;
RT   "A conserved alphabeta transmembrane interface forms the core of a compact
RT   T-cell receptor-CD3 structure within the membrane.";
RL   Proc. Natl. Acad. Sci. U.S.A. 113:E6649-E6658(2016).
RN   [12]
RP   INVOLVEMENT IN IMD7.
RX   PubMed=21206088; DOI=10.1172/jci41931;
RA   Morgan N.V., Goddard S., Cardno T.S., McDonald D., Rahman F., Barge D.,
RA   Ciupek A., Straatman-Iwanowska A., Pasha S., Guckian M., Anderson G.,
RA   Huissoon A., Cant A., Tate W.P., Hambleton S., Maher E.R.;
RT   "Mutation in the TCRalpha subunit constant gene (TRAC) leads to a human
RT   immunodeficiency disorder characterized by a lack of TCRalphabeta+ T
RT   cells.";
RL   J. Clin. Invest. 121:695-702(2011).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (1.5 ANGSTROMS) OF 1-93.
RX   PubMed=12429093; DOI=10.1016/s0969-2126(02)00878-x;
RA   Kjer-Nielsen L., Clements C.S., Brooks A.G., Purcell A.W., McCluskey J.,
RA   Rossjohn J.;
RT   "The 1.5 A crystal structure of a highly selected antiviral T cell receptor
RT   provides evidence for a structural basis of immunodominance.";
RL   Structure 10:1521-1532(2002).
RN   [14]
RP   X-RAY CRYSTALLOGRAPHY (1.4 ANGSTROMS) OF 1-91 IN COMPLEX WITH HLA-A/B2M
RP   HETERODIMER AND TRBC1, AND DISULFIDE BOND.
RX   PubMed=12796775; DOI=10.1038/ni942;
RA   Stewart-Jones G.B.E., McMichael A.J., Bell J.I., Stuart D.I., Jones E.Y.;
RT   "A structural basis for immunodominant human T cell receptor recognition.";
RL   Nat. Immunol. 4:657-663(2003).
RN   [15]
RP   X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF 1-94 IN COMPLEX WITH
RP   HLA-DRA/HLA-DRB5 HETERODIMER AND MBP PEPTIDE.
RX   PubMed=16079912; DOI=10.1038/sj.emboj.7600771;
RA   Li Y., Huang Y., Lue J., Quandt J.A., Martin R., Mariuzza R.A.;
RT   "Structure of a human autoimmune TCR bound to a myelin basic protein self-
RT   peptide and a multiple sclerosis-associated MHC class II molecule.";
RL   EMBO J. 24:2968-2979(2005).
CC   -!- FUNCTION: Constant region of T cell receptor (TR) alpha chain
CC       (PubMed:24600447). Alpha-beta T cell receptors are antigen specific
CC       receptors which are essential to the immune response and are present on
CC       the cell surface of T lymphocytes. Recognize peptide-major
CC       histocompatibility (MH) (pMH) complexes that are displayed by antigen
CC       presenting cells (APC), a prerequisite for efficient T cell adaptive
CC       immunity against pathogens (PubMed:25493333). Binding of alpha-beta TR
CC       to pMH complex initiates TR-CD3 clustering on the cell surface and
CC       intracellular activation of LCK that phosphorylates the ITAM motifs of
CC       CD3G, CD3D, CD3E and CD247 enabling the recruitment of ZAP70. In turn,
CC       ZAP70 phosphorylates LAT, which recruits numerous signaling molecules
CC       to form the LAT signalosome. The LAT signalosome propagates signal
CC       branching to three major signaling pathways, the calcium, the mitogen-
CC       activated protein kinase (MAPK) kinase and the nuclear factor NF-kappa-
CC       B (NF-kB) pathways, leading to the mobilization of transcription
CC       factors that are critical for gene expression and essential for T cell
CC       growth and differentiation (PubMed:23524462). The T cell repertoire is
CC       generated in the thymus, by V-(D)-J rearrangement. This repertoire is
CC       then shaped by intrathymic selection events to generate a peripheral T
CC       cell pool of self-MH restricted, non-autoaggressive T cells. Post-
CC       thymic interaction of alpha-beta TR with the pMH complexes shapes TR
CC       structural and functional avidity (PubMed:15040585).
CC       {ECO:0000303|PubMed:15040585, ECO:0000303|PubMed:23524462,
CC       ECO:0000303|PubMed:24600447, ECO:0000303|PubMed:25493333}.
CC   -!- SUBUNIT: Alpha-beta TR is a heterodimer composed of an alpha and beta
CC       chain; disulfide-linked. The alpha-beta TR is associated with the
CC       transmembrane signaling CD3 coreceptor proteins to form the TR-CD3 (TcR
CC       or TCR). The assembly of alpha-beta TR heterodimers with CD3 occurs in
CC       the endoplasmic reticulum where a single alpha-beta TR heterodimer
CC       associates with one CD3D-CD3E heterodimer, one CD3G-CD3E heterodimer
CC       and one CD247 homodimer forming a stable octameric structure. CD3D-CD3E
CC       and CD3G-CD3E heterodimers preferentially associate with TR alpha and
CC       TR beta chains, respectively. The association of the CD247 homodimer is
CC       the last step of TcR assembly in the endoplasmic reticulum and is
CC       required for transport to the cell surface.
CC       {ECO:0000269|PubMed:27791034, ECO:0000303|PubMed:20452950}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000303|PubMed:20452950}.
CC   -!- DOMAIN: The connecting peptide (CP) domain contributes to the TR-CD3
CC       assembly and signal transduction. {ECO:0000305|PubMed:27791034}.
CC   -!- DOMAIN: The TM domain mediates the interaction with the CD3 subunits.
CC       {ECO:0000269|PubMed:27791034}.
CC   -!- POLYMORPHISM: There are several alleles. The sequence shown is that of
CC       IMGT allele TRAC*01. {ECO:0000305}.
CC   -!- DISEASE: Immunodeficiency 7 (IMD7) [MIM:615387]: A primary
CC       immunodeficiency disorder manifesting with recurrent respiratory
CC       infections, candidiasis, diarrhea, and failure to thrive. Patients show
CC       a clear predisposition to herpes viral infections, and features of
CC       immune dysregulation, including hypereosinophilia, vitiligo, and
CC       alopecia areata. Other features include lymphadenopathy and
CC       hepatosplenomegaly. CD3+ T-cells express TCR-gamma/delta, but little or
CC       no TCR-alpha/beta. {ECO:0000269|PubMed:21206088}. Note=The disease is
CC       caused by variants affecting the gene represented in this entry.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAA26435.1; Type=Miscellaneous discrepancy; Note=Chimeric mRNA corresponding to regions V, J and C of T cell receptor (TR) alpha chain.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X02592; CAA26435.1; ALT_SEQ; mRNA.
DR   EMBL; AC243965; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   PIR; S18893; RWHUAC.
DR   PDB; 1AO7; X-ray; 2.60 A; D=1-93.
DR   PDB; 1BD2; X-ray; 2.50 A; D=1-93.
DR   PDB; 1FYT; X-ray; 2.60 A; D=1-97.
DR   PDB; 1J8H; X-ray; 2.40 A; D=1-97.
DR   PDB; 1KGC; X-ray; 1.50 A; D=1-93.
DR   PDB; 1MI5; X-ray; 2.50 A; D=1-89.
DR   PDB; 1OGA; X-ray; 1.40 A; D=1-95.
DR   PDB; 1QRN; X-ray; 2.80 A; D=1-89.
DR   PDB; 1QSF; X-ray; 2.80 A; D=1-89.
DR   PDB; 1YMM; X-ray; 3.50 A; D=1-94.
DR   PDB; 1ZGL; X-ray; 2.80 A; M/Q/S/U=1-94.
DR   PDB; 2AK4; X-ray; 2.50 A; D/I/N/T=1-93.
DR   PDB; 2BNQ; X-ray; 1.70 A; D=1-89.
DR   PDB; 2BNR; X-ray; 1.90 A; D=1-89.
DR   PDB; 2BNU; X-ray; 1.40 A; A=1-89.
DR   PDB; 2CDF; X-ray; 2.25 A; A=1-78.
DR   PDB; 2CDG; X-ray; 2.60 A; A=1-78.
DR   PDB; 2ESV; X-ray; 2.60 A; D=1-89.
DR   PDB; 2EYR; X-ray; 2.40 A; A=1-93.
DR   PDB; 2EYS; X-ray; 2.21 A; A=1-93.
DR   PDB; 2EYT; X-ray; 2.60 A; A/C=1-93.
DR   PDB; 2F53; X-ray; 2.10 A; D=1-77.
DR   PDB; 2F54; X-ray; 2.70 A; D/K=1-91.
DR   PDB; 2GJ6; X-ray; 2.56 A; D=1-89.
DR   PDB; 2IAL; X-ray; 1.92 A; A/C=1-93.
DR   PDB; 2IAM; X-ray; 2.80 A; C=1-93.
DR   PDB; 2IAN; X-ray; 2.80 A; D/I/N/S=1-93.
DR   PDB; 2NX5; X-ray; 2.70 A; D/I/N/T=1-77.
DR   PDB; 2P5E; X-ray; 1.89 A; D=1-79.
DR   PDB; 2P5W; X-ray; 2.20 A; D=1-77.
DR   PDB; 2PO6; X-ray; 3.20 A; C/G=1-90.
DR   PDB; 2PYE; X-ray; 2.30 A; D=1-79.
DR   PDB; 2PYF; X-ray; 2.20 A; A=1-91.
DR   PDB; 2VLJ; X-ray; 2.40 A; D=1-89.
DR   PDB; 2VLK; X-ray; 2.50 A; D=1-89.
DR   PDB; 2VLM; X-ray; 1.98 A; D=1-89.
DR   PDB; 2VLR; X-ray; 2.30 A; D/I=1-89.
DR   PDB; 2XN9; X-ray; 2.30 A; A=1-93.
DR   PDB; 2XNA; X-ray; 2.10 A; A=1-93.
DR   PDB; 3ARB; X-ray; 2.70 A; C=1-93.
DR   PDB; 3ARD; X-ray; 3.01 A; C=1-93.
DR   PDB; 3ARE; X-ray; 2.80 A; C=1-93.
DR   PDB; 3ARF; X-ray; 2.90 A; C=1-93.
DR   PDB; 3ARG; X-ray; 3.00 A; C=1-93.
DR   PDB; 3D39; X-ray; 2.81 A; D=1-89.
DR   PDB; 3DX9; X-ray; 2.75 A; A/C=1-90.
DR   PDB; 3DXA; X-ray; 3.50 A; D/I/N=1-91.
DR   PDB; 3FFC; X-ray; 2.80 A; D/I=1-89.
DR   PDB; 3GSN; X-ray; 2.80 A; A=1-89.
DR   PDB; 3HE7; X-ray; 2.80 A; C=1-93.
DR   PDB; 3HG1; X-ray; 3.00 A; D=1-85.
DR   PDB; 3KPR; X-ray; 2.60 A; D/I=1-89.
DR   PDB; 3KPS; X-ray; 2.70 A; D=1-89.
DR   PDB; 3KXF; X-ray; 3.10 A; D/G/M/N=1-89.
DR   PDB; 3O4L; X-ray; 2.54 A; D=1-90.
DR   PDB; 3O6F; X-ray; 2.80 A; C/G=1-90.
DR   PDB; 3O8X; X-ray; 2.74 A; C=1-93.
DR   PDB; 3O9W; X-ray; 2.80 A; C=1-93.
DR   PDB; 3PWP; X-ray; 2.69 A; D=1-89.
DR   PDB; 3QDG; X-ray; 2.69 A; D=1-89.
DR   PDB; 3QDJ; X-ray; 2.30 A; D=1-89.
DR   PDB; 3QDM; X-ray; 2.80 A; D=1-87.
DR   PDB; 3QEQ; X-ray; 2.59 A; D=1-86.
DR   PDB; 3QEU; X-ray; 2.09 A; A/D=1-91.
DR   PDB; 3QIB; X-ray; 2.70 A; C=1-93.
DR   PDB; 3QJF; X-ray; 2.40 A; A/C=1-93.
DR   PDB; 3QUX; X-ray; 2.91 A; C=1-93.
DR   PDB; 3SCM; X-ray; 2.50 A; C=1-93.
DR   PDB; 3SDA; X-ray; 2.80 A; C=1-93.
DR   PDB; 3SDC; X-ray; 3.10 A; C=1-93.
DR   PDB; 3SDD; X-ray; 3.00 A; C=1-93.
DR   PDB; 3SDX; X-ray; 3.12 A; E/G=1-90.
DR   PDB; 3SJV; X-ray; 3.10 A; D/I/N/S=1-93.
DR   PDB; 3SKN; X-ray; 2.90 A; A/C/E/G=1-93.
DR   PDB; 3T0E; X-ray; 4.00 A; C=1-94.
DR   PDB; 3TN0; X-ray; 3.20 A; C=1-93.
DR   PDB; 3TVM; X-ray; 2.80 A; C/G=1-93.
DR   PDB; 4APQ; X-ray; 3.00 A; C=1-93.
DR   PDB; 4C56; X-ray; 2.90 A; A/G=1-93.
DR   PDB; 4G8E; X-ray; 2.20 A; A=1-90.
DR   PDB; 4G8F; X-ray; 2.10 A; A=1-93.
DR   PDB; 4IRS; X-ray; 2.80 A; C=1-93.
DR   PDB; 4JFD; X-ray; 2.46 A; D=1-86.
DR   PDB; 4JFE; X-ray; 2.70 A; D=1-87.
DR   PDB; 4JFF; X-ray; 2.43 A; D=1-87.
DR   PDB; 4JFH; X-ray; 2.40 A; D=1-90.
DR   PDB; 4JRX; X-ray; 2.30 A; D=1-89.
DR   PDB; 4JRY; X-ray; 2.80 A; D=1-89.
DR   PDB; 4MVB; X-ray; 3.09 A; A=1-93.
DR   PDB; 4MXQ; X-ray; 2.60 A; C=1-93.
DR   PDB; 4N0C; X-ray; 2.90 A; C/G=1-93.
DR   PDB; 4N5E; X-ray; 3.06 A; C=1-93.
DR   PDB; 4NHU; X-ray; 2.90 A; A/C=1-93.
DR   PDB; 4ONH; X-ray; 3.01 A; A=1-93.
DR   PDB; 4P4K; X-ray; 2.80 A; C/G=1-93.
DR   PDB; 4PRH; X-ray; 2.50 A; D=1-93.
DR   PDB; 4PRI; X-ray; 2.40 A; D=1-89.
DR   PDB; 4PRP; X-ray; 2.50 A; D=1-89.
DR   PDB; 4UDT; X-ray; 1.35 A; A=1-93.
DR   PDB; 4UDU; X-ray; 2.50 A; A=1-93.
DR   PDB; 4WW1; X-ray; 1.38 A; A=1-93.
DR   PDB; 4WW2; X-ray; 2.48 A; A=1-93.
DR   PDB; 4WWK; X-ray; 3.10 A; A=1-93.
DR   PDB; 4X6B; X-ray; 2.10 A; A/C=1-93.
DR   PDB; 4X6C; X-ray; 2.80 A; E/G=1-93.
DR   PDB; 4X6D; X-ray; 2.98 A; E/G=1-93.
DR   PDB; 4Y16; X-ray; 2.60 A; C=1-93.
DR   PDB; 4Y2D; X-ray; 3.05 A; C/G=1-93.
DR   PDB; 4Y4F; X-ray; 3.19 A; C/G=1-93.
DR   PDB; 4Y4H; X-ray; 3.10 A; C/G=1-93.
DR   PDB; 4Y4K; X-ray; 2.90 A; C=1-93.
DR   PDB; 4ZDH; X-ray; 2.10 A; A=1-91.
DR   PDB; 5BRZ; X-ray; 2.62 A; D=2-82.
DR   PDB; 5BS0; X-ray; 2.40 A; D=1-82.
DR   PDB; 5C07; X-ray; 2.11 A; D/I=1-88.
DR   PDB; 5C08; X-ray; 2.33 A; D/I=1-80.
DR   PDB; 5C09; X-ray; 2.48 A; D/I=1-90.
DR   PDB; 5C0A; X-ray; 2.46 A; D/I=1-87.
DR   PDB; 5C0B; X-ray; 2.03 A; D/I=1-89.
DR   PDB; 5C0C; X-ray; 1.97 A; D/I=1-89.
DR   PDB; 5EU6; X-ray; 2.02 A; D=1-87.
DR   PDB; 5FK9; X-ray; 3.10 A; A=1-93.
DR   PDB; 5FKA; X-ray; 2.40 A; A=1-93.
DR   PDB; 5HHM; X-ray; 2.50 A; D/I=1-89.
DR   PDB; 5HHO; X-ray; 2.95 A; D=1-89.
DR   PDB; 5HYJ; X-ray; 3.06 A; D/I=1-82.
DR   PDB; 5JZI; X-ray; 2.50 A; G/I=1-93.
DR   PDB; 5KS9; X-ray; 2.55 A; E/G=1-93.
DR   PDB; 5KSA; X-ray; 2.00 A; C=1-93.
DR   PDB; 5KSB; X-ray; 2.90 A; E/G=1-93.
DR   PDB; 5NQK; X-ray; 3.25 A; A=1-91.
DR   PDB; 6DKP; X-ray; 2.97 A; D=1-89.
DR   PDB; 6JXR; EM; 3.70 A; m=1-140.
DR   PDB; 7FJD; EM; 3.20 A; m=1-140.
DR   PDB; 7FJE; EM; 3.00 A; m=1-140.
DR   PDB; 7FJF; EM; 3.10 A; m=1-140.
DR   PDB; 7NDT; X-ray; 3.00 A; DDD/III=1-85.
DR   PDB; 7RYL; X-ray; 2.00 A; D=1-93.
DR   PDB; 7RYM; X-ray; 3.20 A; D=1-93.
DR   PDB; 7RYN; X-ray; 2.70 A; D=1-93.
DR   PDB; 7RYO; X-ray; 3.00 A; D=1-93.
DR   PDB; 7T2B; X-ray; 2.80 A; D/I/N/S=1-93.
DR   PDB; 7T2C; X-ray; 3.10 A; D=1-93.
DR   PDB; 7T2D; X-ray; 3.40 A; D/I/N/S=1-93.
DR   PDB; 8RRO; X-ray; 3.50 A; A/F/K/P/U/Z/e/j=1-90.
DR   PDB; 8RVD; X-ray; 3.00 A; B/D/G/H/J/L/N/P=1-93.
DR   PDB; 8TW4; EM; 3.30 A; A=1-140.
DR   PDB; 8Y6X; X-ray; 3.40 A; D=1-93.
DR   PDB; 8YIV; X-ray; 2.10 A; D=1-93.
DR   PDB; 8YJ2; X-ray; 2.26 A; D=1-93.
DR   PDB; 8YJ3; X-ray; 3.50 A; B/D/F/H=1-93.
DR   PDB; 9BBC; EM; 3.30 A; A=1-139.
DR   PDB; 9C3E; EM; 3.50 A; A=1-138.
DR   PDBsum; 1AO7; -.
DR   PDBsum; 1BD2; -.
DR   PDBsum; 1FYT; -.
DR   PDBsum; 1J8H; -.
DR   PDBsum; 1KGC; -.
DR   PDBsum; 1MI5; -.
DR   PDBsum; 1OGA; -.
DR   PDBsum; 1QRN; -.
DR   PDBsum; 1QSF; -.
DR   PDBsum; 1YMM; -.
DR   PDBsum; 1ZGL; -.
DR   PDBsum; 2AK4; -.
DR   PDBsum; 2BNQ; -.
DR   PDBsum; 2BNR; -.
DR   PDBsum; 2BNU; -.
DR   PDBsum; 2CDF; -.
DR   PDBsum; 2CDG; -.
DR   PDBsum; 2ESV; -.
DR   PDBsum; 2EYR; -.
DR   PDBsum; 2EYS; -.
DR   PDBsum; 2EYT; -.
DR   PDBsum; 2F53; -.
DR   PDBsum; 2F54; -.
DR   PDBsum; 2GJ6; -.
DR   PDBsum; 2IAL; -.
DR   PDBsum; 2IAM; -.
DR   PDBsum; 2IAN; -.
DR   PDBsum; 2NX5; -.
DR   PDBsum; 2P5E; -.
DR   PDBsum; 2P5W; -.
DR   PDBsum; 2PO6; -.
DR   PDBsum; 2PYE; -.
DR   PDBsum; 2PYF; -.
DR   PDBsum; 2VLJ; -.
DR   PDBsum; 2VLK; -.
DR   PDBsum; 2VLM; -.
DR   PDBsum; 2VLR; -.
DR   PDBsum; 2XN9; -.
DR   PDBsum; 2XNA; -.
DR   PDBsum; 3ARB; -.
DR   PDBsum; 3ARD; -.
DR   PDBsum; 3ARE; -.
DR   PDBsum; 3ARF; -.
DR   PDBsum; 3ARG; -.
DR   PDBsum; 3D39; -.
DR   PDBsum; 3DX9; -.
DR   PDBsum; 3DXA; -.
DR   PDBsum; 3FFC; -.
DR   PDBsum; 3GSN; -.
DR   PDBsum; 3HE7; -.
DR   PDBsum; 3HG1; -.
DR   PDBsum; 3KPR; -.
DR   PDBsum; 3KPS; -.
DR   PDBsum; 3KXF; -.
DR   PDBsum; 3O4L; -.
DR   PDBsum; 3O6F; -.
DR   PDBsum; 3O8X; -.
DR   PDBsum; 3O9W; -.
DR   PDBsum; 3PWP; -.
DR   PDBsum; 3QDG; -.
DR   PDBsum; 3QDJ; -.
DR   PDBsum; 3QDM; -.
DR   PDBsum; 3QEQ; -.
DR   PDBsum; 3QEU; -.
DR   PDBsum; 3QIB; -.
DR   PDBsum; 3QJF; -.
DR   PDBsum; 3QUX; -.
DR   PDBsum; 3SCM; -.
DR   PDBsum; 3SDA; -.
DR   PDBsum; 3SDC; -.
DR   PDBsum; 3SDD; -.
DR   PDBsum; 3SDX; -.
DR   PDBsum; 3SJV; -.
DR   PDBsum; 3SKN; -.
DR   PDBsum; 3T0E; -.
DR   PDBsum; 3TN0; -.
DR   PDBsum; 3TVM; -.
DR   PDBsum; 4APQ; -.
DR   PDBsum; 4C56; -.
DR   PDBsum; 4G8E; -.
DR   PDBsum; 4G8F; -.
DR   PDBsum; 4IRS; -.
DR   PDBsum; 4JFD; -.
DR   PDBsum; 4JFE; -.
DR   PDBsum; 4JFF; -.
DR   PDBsum; 4JFH; -.
DR   PDBsum; 4JRX; -.
DR   PDBsum; 4JRY; -.
DR   PDBsum; 4MVB; -.
DR   PDBsum; 4MXQ; -.
DR   PDBsum; 4N0C; -.
DR   PDBsum; 4N5E; -.
DR   PDBsum; 4NHU; -.
DR   PDBsum; 4ONH; -.
DR   PDBsum; 4P4K; -.
DR   PDBsum; 4PRH; -.
DR   PDBsum; 4PRI; -.
DR   PDBsum; 4PRP; -.
DR   PDBsum; 4UDT; -.
DR   PDBsum; 4UDU; -.
DR   PDBsum; 4WW1; -.
DR   PDBsum; 4WW2; -.
DR   PDBsum; 4WWK; -.
DR   PDBsum; 4X6B; -.
DR   PDBsum; 4X6C; -.
DR   PDBsum; 4X6D; -.
DR   PDBsum; 4Y16; -.
DR   PDBsum; 4Y2D; -.
DR   PDBsum; 4Y4F; -.
DR   PDBsum; 4Y4H; -.
DR   PDBsum; 4Y4K; -.
DR   PDBsum; 4ZDH; -.
DR   PDBsum; 5BRZ; -.
DR   PDBsum; 5BS0; -.
DR   PDBsum; 5C07; -.
DR   PDBsum; 5C08; -.
DR   PDBsum; 5C09; -.
DR   PDBsum; 5C0A; -.
DR   PDBsum; 5C0B; -.
DR   PDBsum; 5C0C; -.
DR   PDBsum; 5EU6; -.
DR   PDBsum; 5FK9; -.
DR   PDBsum; 5FKA; -.
DR   PDBsum; 5HHM; -.
DR   PDBsum; 5HHO; -.
DR   PDBsum; 5HYJ; -.
DR   PDBsum; 5JZI; -.
DR   PDBsum; 5KS9; -.
DR   PDBsum; 5KSA; -.
DR   PDBsum; 5KSB; -.
DR   PDBsum; 5NQK; -.
DR   PDBsum; 6DKP; -.
DR   PDBsum; 6JXR; -.
DR   PDBsum; 7FJD; -.
DR   PDBsum; 7FJE; -.
DR   PDBsum; 7FJF; -.
DR   PDBsum; 7NDT; -.
DR   PDBsum; 7RYL; -.
DR   PDBsum; 7RYM; -.
DR   PDBsum; 7RYN; -.
DR   PDBsum; 7RYO; -.
DR   PDBsum; 7T2B; -.
DR   PDBsum; 7T2C; -.
DR   PDBsum; 7T2D; -.
DR   PDBsum; 8RRO; -.
DR   PDBsum; 8RVD; -.
DR   PDBsum; 8TW4; -.
DR   PDBsum; 8Y6X; -.
DR   PDBsum; 8YIV; -.
DR   PDBsum; 8YJ2; -.
DR   PDBsum; 8YJ3; -.
DR   PDBsum; 9BBC; -.
DR   PDBsum; 9C3E; -.
DR   AlphaFoldDB; P01848; -.
DR   EMDB; EMD-31618; -.
DR   EMDB; EMD-31619; -.
DR   EMDB; EMD-31620; -.
DR   EMDB; EMD-37929; -.
DR   EMDB; EMD-9895; -.
DR   SMR; P01848; -.
DR   ComplexPortal; CPX-6482; Alpha-beta T cell receptor complex, TRBC2 variant.
DR   ComplexPortal; CPX-6581; Alpha-beta T cell receptor complex, TRBC1 variant.
DR   FunCoup; P01848; 180.
DR   IntAct; P01848; 13.
DR   ChEMBL; CHEMBL3580506; -.
DR   DrugBank; DB02740; 3-Indolebutyric Acid.
DR   IMGT_GENE-DB; TRAC; -.
DR   GlyCosmos; P01848; 4 sites, No reported glycans.
DR   GlyGen; P01848; 4 sites.
DR   iPTMnet; P01848; -.
DR   PhosphoSitePlus; P01848; -.
DR   BioMuta; TRAC; -.
DR   DMDM; 135511; -.
DR   MassIVE; P01848; -.
DR   ProteomicsDB; 51491; -.
DR   UCSC; uc058zhj.1; human.
DR   AGR; HGNC:12029; -.
DR   GeneCards; TRAC; -.
DR   HGNC; HGNC:12029; TRAC.
DR   HPA; ENSG00000277734; Tissue enriched (lymphoid).
DR   MalaCards; TRAC; -.
DR   MIM; 186880; gene.
DR   MIM; 615387; phenotype.
DR   Orphanet; 397959; TCR-alpha-beta-positive T-cell deficiency.
DR   HOGENOM; CLU_092098_1_0_1; -.
DR   InParanoid; P01848; -.
DR   OMA; CNATLIE; -.
DR   OrthoDB; 8947657at2759; -.
DR   PAN-GO; P01848; 1 GO annotation based on evolutionary models.
DR   PhylomeDB; P01848; -.
DR   PathwayCommons; P01848; -.
DR   Reactome; R-HSA-198933; Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell.
DR   Reactome; R-HSA-202424; Downstream TCR signaling.
DR   Reactome; R-HSA-202427; Phosphorylation of CD3 and TCR zeta chains.
DR   Reactome; R-HSA-202430; Translocation of ZAP-70 to Immunological synapse.
DR   Reactome; R-HSA-202433; Generation of second messenger molecules.
DR   Reactome; R-HSA-389948; Co-inhibition by PD-1.
DR   SignaLink; P01848; -.
DR   SIGNOR; P01848; -.
DR   ChiTaRS; TRAC; human.
DR   EvolutionaryTrace; P01848; -.
DR   Pharos; P01848; Tdark.
DR   PRO; PR:P01848; -.
DR   Proteomes; UP000005640; Unplaced.
DR   RNAct; P01848; protein.
DR   GO; GO:0042105; C:alpha-beta T cell receptor complex; IDA:UniProt.
DR   GO; GO:0005886; C:plasma membrane; IDA:ComplexPortal.
DR   GO; GO:0002250; P:adaptive immune response; NAS:ComplexPortal.
DR   GO; GO:0046631; P:alpha-beta T cell activation; NAS:ComplexPortal.
DR   GO; GO:0009617; P:response to bacterium; IBA:GO_Central.
DR   GO; GO:0050852; P:T cell receptor signaling pathway; NAS:ComplexPortal.
DR   CDD; cd07688; IgC_TCR_alpha; 1.
DR   FunFam; 2.60.40.10:FF:003018; T cell receptor alpha constant; 1.
DR   Gene3D; 2.60.40.10; Immunoglobulins; 1.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR015370; TCR_alpha_C.
DR   Pfam; PF09291; DUF1968; 1.
DR   SUPFAM; SSF48726; Immunoglobulin; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Adaptive immunity; Cell membrane; Disulfide bond;
KW   Glycoprotein; Immunity; Membrane; Receptor; Reference proteome;
KW   T cell receptor; Transmembrane; Transmembrane helix.
FT   CHAIN           <1..140
FT                   /note="T cell receptor alpha chain constant"
FT                   /id="PRO_0000184524"
FT   TRANSMEM        116..138
FT                   /note="Helical"
FT                   /evidence="ECO:0000255, ECO:0000269|PubMed:27791034"
FT   TOPO_DOM        139..140
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          19..107
FT                   /note="Ig-like C1-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   REGION          94..115
FT                   /note="Connecting peptide"
FT                   /evidence="ECO:0000305|PubMed:27791034"
FT   CARBOHYD        32
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00498,
FT                   ECO:0000269|PubMed:19349973"
FT   CARBOHYD        66
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00498,
FT                   ECO:0000269|PubMed:19349973"
FT   CARBOHYD        77
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00498"
FT   CARBOHYD        113
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00498"
FT   DISULFID        22..72
FT                   /evidence="ECO:0000269|PubMed:12796775"
FT   DISULFID        94
FT                   /note="Interchain (with C-130 in TRBC1 or TRBC2)"
FT                   /evidence="ECO:0000305|PubMed:27791034"
FT   MUTAGEN         130
FT                   /note="N->L,F: Impairs TR-CD3 complex assembly."
FT                   /evidence="ECO:0000269|PubMed:27791034"
FT   NON_TER         1
FT   STRAND          7..15
FT                   /evidence="ECO:0007829|PDB:4UDT"
FT   STRAND          16..18
FT                   /evidence="ECO:0007829|PDB:2VLR"
FT   STRAND          20..26
FT                   /evidence="ECO:0007829|PDB:4UDT"
FT   STRAND          29..31
FT                   /evidence="ECO:0007829|PDB:4N0C"
FT   STRAND          37..40
FT                   /evidence="ECO:0007829|PDB:5C0C"
FT   STRAND          41..43
FT                   /evidence="ECO:0007829|PDB:4UDT"
FT   STRAND          47..51
FT                   /evidence="ECO:0007829|PDB:4UDT"
FT   HELIX           52..54
FT                   /evidence="ECO:0007829|PDB:4UDT"
FT   STRAND          56..66
FT                   /evidence="ECO:0007829|PDB:4UDT"
FT   STRAND          67..69
FT                   /evidence="ECO:0007829|PDB:2BNU"
FT   HELIX           72..75
FT                   /evidence="ECO:0007829|PDB:4UDT"
FT   TURN            76..78
FT                   /evidence="ECO:0007829|PDB:4UDT"
FT   STRAND          95..98
FT                   /evidence="ECO:0007829|PDB:5JZI"
FT   HELIX           99..101
FT                   /evidence="ECO:0007829|PDB:7FJE"
FT   HELIX           107..139
FT                   /evidence="ECO:0007829|PDB:7FJE"
SQ   SEQUENCE   140 AA;  15717 MW;  CF6B38A0F653035D CRC64;
     IQNPDPAVYQ LRDSKSSDKS VCLFTDFDSQ TNVSQSKDSD VYITDKTVLD MRSMDFKSNS
     AVAWSNKSDF ACANAFNNSI IPEDTFFPSP ESSCDVKLVE KSFETDTNLN FQNLSVIGFR
     ILLLKVAGFN LLMTLRLWSS
//
